Clinical Trial Update: Low Dose Cyclosporin A in Primary Sjögren Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating low-dose Cyclosporin A for primary Sjögren's syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren Syndrome

Drugs mentioned

• Cyclosporin A (cyclosporine)

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Sjögren´s Syndrome | Phase 2 | Status: COMPLETED